Novel 3-oxa lipoxin A4 analogues with enhanced chemical and metabolic stability have anti-inflammatory activity in vivo.
Guilford WJ, Bauman JG, Skuballa W, Bauer S, Wei GP, Davey D, Schaefer C, Mallari C, Terkelsen J, Tseng JL, Shen J, Subramanyam B, Schottelius AJ, Parkinson JF.
Guilford WJ, et al. Among authors: schottelius aj.
J Med Chem. 2004 Apr 8;47(8):2157-65. doi: 10.1021/jm030569l.
J Med Chem. 2004.
PMID: 15056011